
To evaluate the diagnostic performance of the antimüllerian hormone (AMH) level determined using the Access AMH assay for predicting poor ovarian response (POR) defined as ≤4 oocytes retrieved, including the validation of the predefined AMH cutoff of 0.93 ng/mL in both serum and plasma.įifteen private and academic fertility centers (14 in the United States and 1 in Canada).

14 Reproductive Associates of Delaware Fertility, Newark, Delaware.13 Pacific Northwest Fertility, Seattle, Washington.


5 Department of Obstetrics and Gynecology, University of Pennsylvania, Philadelphia, Pennsylvania.4 The Center of Reproductive Medicine, Webster, Texas.Electronic address: 2 Main Line Fertility, Bryn Mawr, Pennsylvania. 1 Division of Reproductive Endocrinology and Infertility, Department of Gynecology and Obstetrics, Johns Hopkins University School of Medicine, Lutherville, Maryland.
